 
							The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Panacea Biotec, one of the leading v...
 
							Last month was World Immunization Week and never has it been a more pertinent milestone. It has been 13 months since the...
 
							The Health Sciences Authority (HSA) at Singapore has extended the authorisation of Pfizer-BioNTech COVID-19 vaccine for ...
 
							A single-dose vaccine that targets new COVID-19 variants has been awarded funding to fast-track testing in human trials....
 
							Moderna, Inc., has announced a new supply agreement with the government of Australia for 25 million doses. Thi...
 
							Shanghai Fosun Pharma has signed a Joint Venture with BioNTech to manufacture mRNA vaccine in China. The JV will ha...
 
							The European Commission has approved a contract for 1.8 billion doses of the BioNTech/Pfizer vaccine. The contract cove...
 
							The U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) for the Pfizer-BioNTech C...
 
							The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency, has...
 
							COVID-19 infections continue to rise with several countries facing second-and third-wave infections with the newly evolv...
 
							The World Health Organisation (WHO) has listed the Sinopharm COVID-19 vaccine for emergency use, giving the green light ...
 
							A malaria vaccine created by scientists at the University of Oxford’s Jenner Institute has been found to be 77% ef...
 
							Moderna, Inc., a US based biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced...
 
							Plans to speed up vaccine development to prevent future pandemics and save lives will be boosted by a UK-hosted summit t...
 
							Thailand's Food and Drug Administration (FDA) has approved Siam Bioscience as a manufacturing facility for COV...
 
							Zuellig Pharma, a Singapore based healthcare services provider in Asia, and Moderna, Inc., a US based biotechnology...
 
							RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and va...
 
							The Victorian Government’s $50 million investment in mRNA vaccine manufacturing is welcome recognition of the worl...
 
									 
									 
									